Accrued Expenses and Other Current Liabilities (Tables)

9 Months Ended

Sep. 30, 2026

Accrued Liabilities, Current [Abstract]

Schedule of Major Components of Accrued Expenses and Other Current Liabilities

The following table provides a summary of the major components of accrued expenses and other current liabilities as reflected on the unaudited condensed consolidated balance sheets (in thousands):


	September 30, 2026		December 31, 2025
Research and development	$	854	$	274
Clinical	566		1,079
Professional fees	941		785
Employee-related	3,229		3,302
Deferred revenue relating to collaborative arrangements	2,426		5,907
Accrued interest expense	4,199		—
Other	468		3,386
Total accrued expenses and other current liabilities	$	12,683	$	14,733